INDIANAPOLIS — A newly approved drug is a sign of hope for thousands of Hoosiers facing Alzheimer’s disease and the loved ones who care for them.
"I'm just, I feel overwhelmed. I've been very emotional today. Because now there's so much hope for other people with the same diagnosis that I have," Patricia Bishara said."When I heard the diagnosis, my first thoughts were, I won't remember my children and my grandchildren's names in five years," Bishara said.
"The new drug is called Kisunla. And it can slow the progression of Alzheimer's disease again when it's provided to those living in the early stages of the disease," Natalie Sutton, Chapter Executive of Alzheimer’s Association Greater Indiana Chapter said.
Source: Law Daily Report (lawdailyreport.net)
Kisunla Alzheimers
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Alzheimer’s Drug with Modest Benefits Gets Green Light from FDA AdvisersThe drug donanemab slows progression of symptoms in people with early stages of Alzheimer’s disease, but questions linger about the durability of its effect
Source: sciam - 🏆 300. / 63 Read more »
AFA responds to approval of Alzheimer’s Drug by FDA Advisory CommitteeThis new drug works by slowing the progression of the disease when administered within the early stages of Alzheimer’s.
Source: KTVF11 - 🏆 267. / 63 Read more »
Independent FDA Panel Endorses New Alzheimer’s Disease TreatmentAn FDA advisory panel unanimously gave a green light on Monday to the Alzheimer’s disease treatment donanemab for use during early stages of the disease.
Source: WebMD - 🏆 709. / 51 Read more »
Experimental Alzheimer’s drug gets FDA advisory panel's thumbs-up: ‘Progress is happening’An experimental Alzheimer’s drug, donanemab, was endorsed by a U.S. Food and Drug Administration advisory panel on Monday. Industry experts and doctors shared reactions.
Source: FoxNews - 🏆 9. / 87 Read more »
FDA panel backs Alzheimer's drug that can reportedly slow cognitive declineRooted in fact-based, transparent reporting, Newsy is an award-winning opinion-free network owned by the E.W. Scripps Company that is relentlessly focused on “the why” of every story and seeks to enable a more intimate and immersive understanding of the issues that matter.
Source: 10News - 🏆 732. / 50 Read more »
Alzheimer's drug that can slow disease gets backing from FDA advisersIf the agency agrees with its advisers, the drug would only be the second Alzheimer's drug approved to slow cognitive decline due to Alzheimer's.
Source: ABC7 - 🏆 67. / 68 Read more »